SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · United Therapeutics CEO Martine Rothblatt and EVP Paul Mahon exercised…

UNITED THERAPEUTICS Corp · CLUSTER filed Mar 17, 2026 at 17:11 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Mar 17, 2026 at 17:11 ET

United Therapeutics CEO Martine Rothblatt and EVP Paul Mahon exercised stock options and sold shares in the open market, generating over $3.7 million in proceeds. The activity is part of a routine stock option exercise and partial sale of shares, not an outright open-market sell-off of owned shares. Director Judy Olian also sold a small portion of her holdings.

  • CEO Martine Rothblatt exercised options for 38,000 shares (across multiple tranches) at $146.03 and $0 strike prices, with total intrinsic value of $4.17 million.
  • Rothblatt sold 679 shares in open-market transactions totaling $356,253 in proceeds.
  • EVP Paul Mahon exercised options for 16,600 shares at $146.03, with intrinsic value of $2.42 million, and sold 753 shares for $397,184.
  • Director Judy Olian sold 200 shares for $106,000 in an open-market transaction.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access